CEMERA, Faculty of Medicine, Universidad de Chile
Santiago, Santiago Metropolitan, 8380455, Chile
NCT Number: NCT06628830
The goal of this clinical trial is to evaluate the efficacy of a mobile phone application for the early intervention of depression and anxiety among young university students in Chile. The main question it aims to answer is:
- Can a mobile app reduce depressive and anxious symptomatology in college students?
Researchers will compare the intervention arm (mobile app users) to the control group (receives psychoeducational material and mental health care resources) to see if the app leads to significant improvements in depressive and anxious symptoms and well-being.
Participants will:
* Be randomly assigned to either the intervention or control group. * Use the mobile application, which includes psychoeducational materials, cognitive-behavioral therapy modules, and periodic personalized feedback. * Complete assessments at baseline, post-intervention, and 3 and 6 months after randomization using online tools such as the PHQ-9 for depressive symptoms and the GAD-7 for anxious symptoms.
Interested in participating?
Request Info18 year–29 year
All sexes
Interventional
Not applicable
Santiago, Santiago Metropolitan, 8380455, Chile
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Psychoeducational materials (videos, information and interactive exercises) about depression, anxiety and social support
Skills training through information and activities based on the principles of cognitive behavioral therapy (cognitive restructuring, behavioral activation, emotional regulation, problem solving and exposure)
mental health psychoeducational campaign (https://concienciasaludable.uchile.cl/)
Time frame: 6-weeks post-randomization
PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
Time frame: 6-weeks post-randomization
GAD-7, total score varies between 0 and 21, higher values represent a worse outcome
Time frame: 6-weeks post-randomization
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
Time frame: 6-weeks post-randomization
Ad-hoc satisfaction questionnaire for the intervention group, total score varies between 7 and 28, higher values represent a better outcome and an overall index with values ranging from 1 to 10
Time frame: 3-months post-randomization
PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
Time frame: 3-months post-randomization
GAD-7, total score varies between 0 and 21, higher values represent a worse outcome
Time frame: 3-months post-randomization
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
Time frame: 6-months post-randomization
PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
Time frame: 6-months post-randomization
GAD-7, total score varies between 0 and 21, higher values represent a worse outcome
Time frame: 6-months post-randomization
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
University of Chile
Other
Efficacy of a Mobile Phone Application for Early Intervention of Depression and Anxiety in Young College Students
Acronym: VamosJuntxs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07375485
Acquired Brain Injury, Anxiety Disorders
Denver, Colorado, United States
View Trial DetailsNCT07717385
Anxiety Disorders, Anxiety Symptoms
New York, United States
View Trial DetailsNCT06315218
Anxiety Disorders, Anxiety Symptoms
View Trial DetailsNCT07607834
Anxiety Disorders, Anxiety Symptoms
Taichung, Taiwan
View Trial Details